Oxford Expression Technologies Ltd is proud to be collaborating with the University of Nottingham, School of Biosciences, as part of the Nottingham BBSRC DLA Programme. Supported by £14 million in funding from the Biotechnology and Biological Sciences Research Council (BBSRC), the University of Nottingham, in partnership with Nottingham Trent University, is offering an innovative, fully funded four-year doctoral training programme focused on frontier bioscience. One of the av

a all-in-one kit for recombinant virus titration using the baculovirus expression system and flashBAC

Oxford Expression Technologies Ltd is delighted to announce the official opening of our new facilities. We were honoured to welcome Calum Miller MP, who officially opened Unit 9, Oxford Technology Park (OTP) on 22nd June 2026. The event was hosted in OTP's new Nexus event space. This important milestone provided an opportunity to celebrate with the many people who have contributed to our success over the years. We would like to extend our sincere thanks to our dedicated staff

Oxford Expression Technologies Ltd. is delighted to announce that we have been invited to attend UK Biotech Day 2026, taking place on 27–28 May 2026 in London. UK Biotech Day brings together the UK and international life sciences community, including biotechnology, pharmaceutical, medtech, techbio, investor, CRO, CDMO, and service-provider organisations. The event provides a platform for collaboration, networking, innovation, and new business opportunities across the sector.

Oxford Expression Technologies Ltd. is delighted to announce that we have been invited to attend the Oxfordshire Innovation Showcase on Monday 18 May 2026. The Showcase celebrates Oxfordshire’s thriving innovation economy, bringing together leading organisations from across science, technology, advanced manufacturing, research, and business. Previous events have highlighted the county’s world-class innovation strengths and the importance of collaboration in supporting future

A Royal Society Industry Fellowship has been awarded to Dr Victor Bolanos-Garcia, at Oxford Brookes University, hosted by Oxford Expression Technologies at our new facilities within Oxford Technology Park. This collaboration will focus on using AI technologies to improve how key viral components are produced for vaccine development, addressing a critical challenge in ensuring viral proteins remain fully active after purification. Solving this issue will help OET accelerate th

OET recently participated in the Viruses 2026: New Horizons in Virology conference held in Barcelona. We had an excellent opportunity to engage with numerous professionals and attend insightful presentations, and we look forward to returning in the future. If you were unable to meet us at the conference or wish to learn more about how OET can assist you, please contact us at info@oetltd.com and we would be pleased to connect with you.

We’re thrilled to share that Oxford Expression Technologies has officially moved into our brand-new home at Oxford Technology Park ,...

Oxford Expression Technologies (OET) is proud to announce our partnership with the upcoming 17th Protein Expression in Animal Cells...

Oxford Expression Technologies (OET) is delighted to announce our participation in the upcoming 9th European Congress of Virology, 2025 ,...

Important Dates for Holiday Period Oxford Expression Technologies (OET) will be closed from Tuesday, 24th December 2024 to Friday, 3rd...

OET has exciting news! This summer we will be visiting the 2024 International Congress on Invertebrate Pathology and Microbial Control...

Please be advised that we will be experiencing a network shutdown on Tuesday, April 2nd that may temporarily impact our ability to...

OET have unfortunately had to change their phone number so the existing number no longer works. However, we now have a new number for you...

OET seeks to recruit an experienced technician to join us at the Bioinnovation Hub, Gipsy Lane, Headington. This will be a key role in...

Novel vaccine platforms are urgently needed to produce efficacious, safe, low cost, and rapidly adaptable (‘plug-and-play’) vaccines to...

CCHFv vaccine - transition from preclinical to clinical studies Crimean Congo Haemorrhagic Fever virus (CCHFv) is endemic in >30...

The polyhedrin gene promoter is the general work horse used for protein expression in the baculovirus system. It is active in the very...

Please note, the last date for shipping of the orders will be Monday 18th December 2023 UK, across the world (except USA). For USA, last...

As the holiday season creeps painfully slowly towards us it’s not only the lab staff who need a little TLC over the festive break. Cell...